CA1314794C - Essai pour detecter les sequences d'acides nucleiques dans un echantillon - Google Patents

Essai pour detecter les sequences d'acides nucleiques dans un echantillon

Info

Publication number: CA1314794C
Authority: CA; Canada
Prior art keywords: sample; nucleic acid; dna; hybridization; nucleic acids
Prior art date: 1986-12-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA000553597A

Other languages

English (en)

Inventor

Nanibhushan Dattagupta

Peter M. M. Rae

Edward D. Huguenel

Daniel U. Rabin

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Molecular Diagnostics Inc

Original Assignee

Molecular Diagnostics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-29

Filing date

1987-12-04

Publication date

1993-03-23

1987-12-04 Application filed by Molecular Diagnostics Inc filed Critical Molecular Diagnostics Inc

1993-03-23 Application granted granted Critical

1993-03-23 Publication of CA1314794C publication Critical patent/CA1314794C/fr

2010-03-23 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

150000007523 nucleic acids Chemical group 0.000 title claims abstract description 99
238000003556 assay Methods 0.000 title description 15
108091028043 Nucleic acid sequence Proteins 0.000 title description 4
239000000523 sample Substances 0.000 claims abstract description 169
238000009396 hybridization Methods 0.000 claims abstract description 91
102000039446 nucleic acids Human genes 0.000 claims abstract description 90
108020004707 nucleic acids Proteins 0.000 claims abstract description 90
238000000034 method Methods 0.000 claims abstract description 77
238000012360 testing method Methods 0.000 claims abstract description 44
238000002372 labelling Methods 0.000 claims abstract description 36
244000005700 microbiome Species 0.000 claims abstract description 14
108020004711 Nucleic Acid Probes Proteins 0.000 claims abstract description 5
239000002853 nucleic acid probe Substances 0.000 claims abstract description 5
210000004027 cell Anatomy 0.000 claims description 32
210000002700 urine Anatomy 0.000 claims description 20
-1 haptens Substances 0.000 claims description 19
239000007787 solid Substances 0.000 claims description 18
108090000623 proteins and genes Proteins 0.000 claims description 17
230000009089 cytolysis Effects 0.000 claims description 16
239000003446 ligand Substances 0.000 claims description 15
102000004190 Enzymes Human genes 0.000 claims description 13
108090000790 Enzymes Proteins 0.000 claims description 13
239000002157 polynucleotide Substances 0.000 claims description 13
102000040430 polynucleotide Human genes 0.000 claims description 12
108091033319 polynucleotide Proteins 0.000 claims description 12
239000002202 Polyethylene glycol Substances 0.000 claims description 11
230000027455 binding Effects 0.000 claims description 11
229920001223 polyethylene glycol Polymers 0.000 claims description 11
241000588769 Proteus <enterobacteria> Species 0.000 claims description 5
238000005119 centrifugation Methods 0.000 claims description 5
102000004169 proteins and genes Human genes 0.000 claims description 5
241000588748 Klebsiella Species 0.000 claims description 4
239000003513 alkali Substances 0.000 claims description 4
238000000746 purification Methods 0.000 claims description 4
230000002285 radioactive effect Effects 0.000 claims description 4
238000001179 sorption measurement Methods 0.000 claims description 4
241000195493 Cryptophyta Species 0.000 claims description 3
241000233866 Fungi Species 0.000 claims description 3
241000186660 Lactobacillus Species 0.000 claims description 3
108020005187 Oligonucleotide Probes Proteins 0.000 claims description 3
241000589516 Pseudomonas Species 0.000 claims description 3
241000191940 Staphylococcus Species 0.000 claims description 3
241000194017 Streptococcus Species 0.000 claims description 3
239000008280 blood Substances 0.000 claims description 3
210000004369 blood Anatomy 0.000 claims description 3
210000001175 cerebrospinal fluid Anatomy 0.000 claims description 3
230000008878 coupling Effects 0.000 claims description 3
238000010168 coupling process Methods 0.000 claims description 3
238000005859 coupling reaction Methods 0.000 claims description 3
229940039696 lactobacillus Drugs 0.000 claims description 3
239000002751 oligonucleotide probe Substances 0.000 claims description 3
241000588722 Escherichia Species 0.000 claims description 2
241001467460 Myxogastria Species 0.000 claims description 2
206010036790 Productive cough Diseases 0.000 claims description 2
210000004381 amniotic fluid Anatomy 0.000 claims description 2
239000000427 antigen Substances 0.000 claims description 2
108091007433 antigens Proteins 0.000 claims description 2
102000036639 antigens Human genes 0.000 claims description 2
239000000975 dye Substances 0.000 claims description 2
238000001914 filtration Methods 0.000 claims description 2
210000004392 genitalia Anatomy 0.000 claims description 2
210000004072 lung Anatomy 0.000 claims description 2
239000006166 lysate Substances 0.000 claims description 2
210000004915 pus Anatomy 0.000 claims description 2
210000003296 saliva Anatomy 0.000 claims description 2
210000003802 sputum Anatomy 0.000 claims description 2
208000024794 sputum Diseases 0.000 claims description 2
210000001138 tear Anatomy 0.000 claims description 2
210000001519 tissue Anatomy 0.000 claims description 2
239000012472 biological sample Substances 0.000 claims 2
210000003756 cervix mucus Anatomy 0.000 claims 1
239000007850 fluorescent dye Substances 0.000 claims 1
238000002955 isolation Methods 0.000 claims 1
210000004962 mammalian cell Anatomy 0.000 claims 1
206010046901 vaginal discharge Diseases 0.000 claims 1
208000026350 Inborn Genetic disease Diseases 0.000 abstract description 4
208000016361 genetic disease Diseases 0.000 abstract description 4
208000007056 sickle cell anemia Diseases 0.000 abstract description 4
108020004414 DNA Proteins 0.000 description 94
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 61
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 44
238000001514 detection method Methods 0.000 description 41
239000000243 solution Substances 0.000 description 37
239000000203 mixture Substances 0.000 description 24
239000000047 product Substances 0.000 description 23
239000000020 Nitrocellulose Substances 0.000 description 20
229920001220 nitrocellulos Polymers 0.000 description 20
108091034117 Oligonucleotide Proteins 0.000 description 19
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 16
241000894006 Bacteria Species 0.000 description 16
239000003153 chemical reaction reagent Substances 0.000 description 16
150000001875 compounds Chemical class 0.000 description 16
239000000138 intercalating agent Substances 0.000 description 15
ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 15
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
239000002253 acid Substances 0.000 description 13
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
229940088598 enzyme Drugs 0.000 description 12
238000002360 preparation method Methods 0.000 description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
108091005902 Hemoglobin subunit alpha Proteins 0.000 description 11
241000282414 Homo sapiens Species 0.000 description 11
239000000872 buffer Substances 0.000 description 11
230000000295 complement effect Effects 0.000 description 11
241000894007 species Species 0.000 description 11
238000006243 chemical reaction Methods 0.000 description 10
150000002500 ions Chemical class 0.000 description 10
102000053602 DNA Human genes 0.000 description 9
239000004677 Nylon Substances 0.000 description 9
229960002685 biotin Drugs 0.000 description 9
239000011616 biotin Substances 0.000 description 9
238000003745 diagnosis Methods 0.000 description 9
239000012528 membrane Substances 0.000 description 9
229920001778 nylon Polymers 0.000 description 9
208000019206 urinary tract infection Diseases 0.000 description 9
108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
108091003079 Bovine Serum Albumin Proteins 0.000 description 8
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
239000002585 base Substances 0.000 description 8
235000020958 biotin Nutrition 0.000 description 8
229940098773 bovine serum albumin Drugs 0.000 description 8
208000015181 infectious disease Diseases 0.000 description 8
239000000463 material Substances 0.000 description 8
230000004568 DNA-binding Effects 0.000 description 7
241000588724 Escherichia coli Species 0.000 description 7
108091005904 Hemoglobin subunit beta Proteins 0.000 description 7
230000008569 process Effects 0.000 description 7
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
239000013592 cell lysate Substances 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
235000013861 fat-free Nutrition 0.000 description 6
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
125000006850 spacer group Chemical group 0.000 description 6
239000000126 substance Substances 0.000 description 6
239000000725 suspension Substances 0.000 description 6
VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 5
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 5
102100027685 Hemoglobin subunit alpha Human genes 0.000 description 5
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
201000006288 alpha thalassemia Diseases 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
229960000633 dextran sulfate Drugs 0.000 description 5
238000010790 dilution Methods 0.000 description 5
239000012895 dilution Substances 0.000 description 5
201000010099 disease Diseases 0.000 description 5
235000013336 milk Nutrition 0.000 description 5
239000008267 milk Substances 0.000 description 5
210000004080 milk Anatomy 0.000 description 5
150000003254 radicals Chemical class 0.000 description 5
238000005406 washing Methods 0.000 description 5
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 4
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
108010054147 Hemoglobins Proteins 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
239000007983 Tris buffer Substances 0.000 description 4
238000002835 absorbance Methods 0.000 description 4
150000007513 acids Chemical class 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
229910052681 coesite Inorganic materials 0.000 description 4
229910052906 cristobalite Inorganic materials 0.000 description 4
239000003599 detergent Substances 0.000 description 4
239000000706 filtrate Substances 0.000 description 4
239000012634 fragment Substances 0.000 description 4
230000035772 mutation Effects 0.000 description 4
239000002773 nucleotide Substances 0.000 description 4
125000003729 nucleotide group Chemical group 0.000 description 4
238000000926 separation method Methods 0.000 description 4
239000000377 silicon dioxide Substances 0.000 description 4
235000012239 silicon dioxide Nutrition 0.000 description 4
239000011734 sodium Substances 0.000 description 4
239000007790 solid phase Substances 0.000 description 4
229910052682 stishovite Inorganic materials 0.000 description 4
239000000758 substrate Substances 0.000 description 4
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
229910052905 tridymite Inorganic materials 0.000 description 4
239000013598 vector Substances 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
108020000946 Bacterial DNA Proteins 0.000 description 3
102000001554 Hemoglobins Human genes 0.000 description 3
102000003960 Ligases Human genes 0.000 description 3
108090000364 Ligases Proteins 0.000 description 3
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
208000002903 Thalassemia Diseases 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
238000000376 autoradiography Methods 0.000 description 3
238000004925 denaturation Methods 0.000 description 3
230000036425 denaturation Effects 0.000 description 3
238000011161 development Methods 0.000 description 3
238000012224 gene deletion Methods 0.000 description 3
230000003100 immobilizing effect Effects 0.000 description 3
229910001629 magnesium chloride Inorganic materials 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
230000002906 microbiologic effect Effects 0.000 description 3
238000002156 mixing Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
238000006386 neutralization reaction Methods 0.000 description 3
RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 3
230000000704 physical effect Effects 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
239000000843 powder Substances 0.000 description 3
239000002244 precipitate Substances 0.000 description 3
229950005143 sitosterol Drugs 0.000 description 3
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
AASBXERNXVFUEJ-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) propanoate Chemical compound CCC(=O)ON1C(=O)CCC1=O AASBXERNXVFUEJ-UHFFFAOYSA-N 0.000 description 2
AXTADRUCVAUCRS-UHFFFAOYSA-N 1-(2-hydroxyethyl)pyrrole-2,5-dione Chemical compound OCCN1C(=O)C=CC1=O AXTADRUCVAUCRS-UHFFFAOYSA-N 0.000 description 2
ZIZXHPCBPDNLDD-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(4-methylphenyl)sulfonyloxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCCOCCOCCOCCOCCOCCOS(=O)(=O)C1=CC=C(C)C=C1 ZIZXHPCBPDNLDD-UHFFFAOYSA-N 0.000 description 2
SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 2
IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 2
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
239000005695 Ammonium acetate Substances 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
108090001008 Avidin Proteins 0.000 description 2
101150041968 CDC13 gene Proteins 0.000 description 2
241000222120 Candida <Saccharomycetales> Species 0.000 description 2
239000004215 Carbon black (E152) Substances 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
241000588914 Enterobacter Species 0.000 description 2
241000194032 Enterococcus faecalis Species 0.000 description 2
241000206602 Eukaryota Species 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
108020004682 Single-Stranded DNA Proteins 0.000 description 2
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
108700009899 Type 1 Spherocytosis Proteins 0.000 description 2
PGAVKCOVUIYSFO-XVFCMESISA-N UTP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-XVFCMESISA-N 0.000 description 2
239000000999 acridine dye Substances 0.000 description 2
238000013019 agitation Methods 0.000 description 2
230000004075 alteration Effects 0.000 description 2
235000019257 ammonium acetate Nutrition 0.000 description 2
229940043376 ammonium acetate Drugs 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
208000007502 anemia Diseases 0.000 description 2
230000001745 anti-biotin effect Effects 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
150000001540 azides Chemical class 0.000 description 2
239000011324 bead Substances 0.000 description 2
230000008901 benefit Effects 0.000 description 2
102000005936 beta-Galactosidase Human genes 0.000 description 2
108010005774 beta-Galactosidase Proteins 0.000 description 2
238000009835 boiling Methods 0.000 description 2
229910021538 borax Inorganic materials 0.000 description 2
239000006285 cell suspension Substances 0.000 description 2
125000003636 chemical group Chemical group 0.000 description 2
238000010367 cloning Methods 0.000 description 2
239000005515 coenzyme Substances 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
230000007547 defect Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
229960002086 dextran Drugs 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000012530 fluid Substances 0.000 description 2
ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
230000009395 genetic defect Effects 0.000 description 2
108060003196 globin Proteins 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
210000003917 human chromosome Anatomy 0.000 description 2
229930195733 hydrocarbon Natural products 0.000 description 2
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000003993 interaction Effects 0.000 description 2
238000009830 intercalation Methods 0.000 description 2
XDROKJSWHURZGO-UHFFFAOYSA-N isopsoralen Natural products C1=C2OC=CC2=C2OC(=O)C=CC2=C1 XDROKJSWHURZGO-UHFFFAOYSA-N 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 2
230000002934 lysing effect Effects 0.000 description 2
235000010335 lysozyme Nutrition 0.000 description 2
238000005259 measurement Methods 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
230000003472 neutralizing effect Effects 0.000 description 2
238000007899 nucleic acid hybridization Methods 0.000 description 2
239000008188 pellet Substances 0.000 description 2
239000012071 phase Substances 0.000 description 2
150000005053 phenanthridines Chemical class 0.000 description 2
125000001484 phenothiazinyl group Chemical class C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
238000012545 processing Methods 0.000 description 2
MLMVLVJMKDPYBM-UHFFFAOYSA-N pseudoisopsoralene Natural products C1=C2C=COC2=C2OC(=O)C=CC2=C1 MLMVLVJMKDPYBM-UHFFFAOYSA-N 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
239000004332 silver Substances 0.000 description 2
229910052709 silver Inorganic materials 0.000 description 2
KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical class C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
239000001509 sodium citrate Substances 0.000 description 2
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 2
229940048086 sodium pyrophosphate Drugs 0.000 description 2
235000010339 sodium tetraborate Nutrition 0.000 description 2
239000011343 solid material Substances 0.000 description 2
PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
235000019818 tetrasodium diphosphate Nutrition 0.000 description 2
239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
229940113082 thymine Drugs 0.000 description 2
BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 2
229950010342 uridine triphosphate Drugs 0.000 description 2
PGAVKCOVUIYSFO-UHFFFAOYSA-N uridine-triphosphate Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-UHFFFAOYSA-N 0.000 description 2
239000012130 whole-cell lysate Substances 0.000 description 2
KUWPCJHYPSUOFW-SCWFEDMQSA-N (2r,3r,4s,5r)-2-(hydroxymethyl)-6-(2-nitrophenoxy)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)OC1OC1=CC=CC=C1[N+]([O-])=O KUWPCJHYPSUOFW-SCWFEDMQSA-N 0.000 description 1
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
CJIZUIJHMKWTKQ-UHFFFAOYSA-N 1-(trioxidanylperoxy)dodecane Chemical compound CCCCCCCCCCCCOOOOO CJIZUIJHMKWTKQ-UHFFFAOYSA-N 0.000 description 1
PQRFAYUCTLLEGK-UHFFFAOYSA-N 1-azidoacridine Chemical compound C1=CC=C2C=C3C(N=[N+]=[N-])=CC=CC3=NC2=C1 PQRFAYUCTLLEGK-UHFFFAOYSA-N 0.000 description 1
WZSDWSACAGBYQU-UHFFFAOYSA-N 2-(dimethylamino)-3-phenylprop-2-enal Chemical compound CN(C)C(C=O)=CC1=CC=CC=C1 WZSDWSACAGBYQU-UHFFFAOYSA-N 0.000 description 1
FOOPZYBJIJNBLQ-UHFFFAOYSA-N 2-[2-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanamine Chemical compound NCCOCCOCCOCCOCCOCCN FOOPZYBJIJNBLQ-UHFFFAOYSA-N 0.000 description 1
NHXWOZNNPSXUKN-UHFFFAOYSA-N 2-azido-9h-fluorene Chemical compound C1=CC=C2C3=CC=C(N=[N+]=[N-])C=C3CC2=C1 NHXWOZNNPSXUKN-UHFFFAOYSA-N 0.000 description 1
HYDWALOBQJFOMS-UHFFFAOYSA-N 3,6,9,12,15-pentaoxaheptadecane Chemical class CCOCCOCCOCCOCCOCC HYDWALOBQJFOMS-UHFFFAOYSA-N 0.000 description 1
GZFVOFMKXXTWQE-UHFFFAOYSA-N 3,8-diazido-5-ethyl-6-phenylphenanthridin-5-ium Chemical compound C12=CC(N=[N+]=[N-])=CC=C2C2=CC=C(N=[N+]=[N-])C=C2[N+](CC)=C1C1=CC=CC=C1 GZFVOFMKXXTWQE-UHFFFAOYSA-N 0.000 description 1
WBIICVGYYRRURR-UHFFFAOYSA-N 3-(aminomethyl)-2,5,9-trimethylfuro[3,2-g]chromen-7-one Chemical compound O1C(=O)C=C(C)C2=C1C(C)=C1OC(C)=C(CN)C1=C2 WBIICVGYYRRURR-UHFFFAOYSA-N 0.000 description 1
BRLRJZRHRJEWJY-VCOUNFBDSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-[3-[3-(4-azido-2-nitroanilino)propyl-methylamino]propyl]pentanamide Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)NCCCN(C)CCCNC1=CC=C(N=[N+]=[N-])C=C1[N+]([O-])=O BRLRJZRHRJEWJY-VCOUNFBDSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 1
201000004569 Blindness Diseases 0.000 description 1
238000009631 Broth culture Methods 0.000 description 1
101100037762 Caenorhabditis elegans rnh-2 gene Proteins 0.000 description 1
241000283707 Capra Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
206010008723 Chondrodystrophy Diseases 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
208000026372 Congenital cystic kidney disease Diseases 0.000 description 1
201000003883 Cystic fibrosis Diseases 0.000 description 1
206010011778 Cystinuria Diseases 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
238000007900 DNA-DNA hybridization Methods 0.000 description 1
101150054335 DNA-R gene Proteins 0.000 description 1
206010011878 Deafness Diseases 0.000 description 1
101150105088 Dele1 gene Proteins 0.000 description 1
108010016626 Dipeptides Proteins 0.000 description 1
SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
101100130497 Drosophila melanogaster Mical gene Proteins 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
241001517310 Eria Species 0.000 description 1
108700039887 Essential Genes Proteins 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
208000027472 Galactosemias Diseases 0.000 description 1
206010018612 Gonorrhoea Diseases 0.000 description 1
102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
101710132405 Hemoglobin subunit beta-A Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
206010020365 Homocystinuria Diseases 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
208000023105 Huntington disease Diseases 0.000 description 1
241000243251 Hydra Species 0.000 description 1
208000035150 Hypercholesterolemia Diseases 0.000 description 1
241000588747 Klebsiella pneumoniae Species 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
108090000988 Lysostaphin Proteins 0.000 description 1
208000001826 Marfan syndrome Diseases 0.000 description 1
201000009906 Meningitis Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
229930192392 Mitomycin Natural products 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
101100345589 Mus musculus Mical1 gene Proteins 0.000 description 1
206010068871 Myotonic dystrophy Diseases 0.000 description 1
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
229910017974 NH40H Inorganic materials 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
201000011252 Phenylketonuria Diseases 0.000 description 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
239000004721 Polyphenylene oxide Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
241000097929 Porphyria Species 0.000 description 1
206010036182 Porphyria acute Diseases 0.000 description 1
208000033141 Porphyria variegata Diseases 0.000 description 1
208000010642 Porphyrias Diseases 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102100029028 Protoporphyrinogen oxidase Human genes 0.000 description 1
201000000582 Retinoblastoma Diseases 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
208000034189 Sclerosis Diseases 0.000 description 1
ATHGHQPFGPMSJY-UHFFFAOYSA-N Spermidine Natural products NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 1
241000024109 Spiris Species 0.000 description 1
241000191963 Staphylococcus epidermidis Species 0.000 description 1
241001221452 Staphylococcus faecalis Species 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
JXASPPWQHFOWPL-UHFFFAOYSA-N Tamarixin Natural products C1=C(O)C(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 JXASPPWQHFOWPL-UHFFFAOYSA-N 0.000 description 1
208000022292 Tay-Sachs disease Diseases 0.000 description 1
206010043391 Thalassaemia beta Diseases 0.000 description 1
206010049808 Thanatophoric dwarfism Diseases 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 1
201000011053 Variegate Porphyria Diseases 0.000 description 1
241000700605 Viruses Species 0.000 description 1
208000008919 achondroplasia Diseases 0.000 description 1
238000010306 acid treatment Methods 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
239000008272 agar Substances 0.000 description 1
208000006682 alpha 1-Antitrypsin Deficiency Diseases 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
108010053584 alpha-Globins Proteins 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
229920006318 anionic polymer Polymers 0.000 description 1
238000000137 annealing Methods 0.000 description 1
229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000012300 argon atmosphere Substances 0.000 description 1
101150024767 arnT gene Proteins 0.000 description 1
238000002820 assay format Methods 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
150000001541 aziridines Chemical class 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000000721 bacterilogical effect Effects 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
229920001222 biopolymer Polymers 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
230000006287 biotinylation Effects 0.000 description 1
238000007413 biotinylation Methods 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
108091092356 cellular DNA Proteins 0.000 description 1
230000008859 change Effects 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
208000029664 classic familial adenomatous polyposis Diseases 0.000 description 1
208000016653 cleft lip/palate Diseases 0.000 description 1
238000009535 clinical urine test Methods 0.000 description 1
238000004737 colorimetric analysis Methods 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
231100000895 deafness Toxicity 0.000 description 1
230000007423 decrease Effects 0.000 description 1
238000001212 derivatisation Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
125000005442 diisocyanate group Chemical group 0.000 description 1
239000000539 dimer Substances 0.000 description 1
238000004821 distillation Methods 0.000 description 1
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
229940043264 dodecyl sulfate Drugs 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
210000005069 ears Anatomy 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
150000002118 epoxides Chemical class 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
YKWNUSJLICDQEO-UHFFFAOYSA-N ethoxyethane;propan-2-ol Chemical compound CC(C)O.CCOCC YKWNUSJLICDQEO-UHFFFAOYSA-N 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
239000012065 filter cake Substances 0.000 description 1
239000012467 final product Substances 0.000 description 1
238000001917 fluorescence detection Methods 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
229940015043 glyoxal Drugs 0.000 description 1
208000001786 gonorrhea Diseases 0.000 description 1
150000004820 halides Chemical class 0.000 description 1
208000016354 hearing loss disease Diseases 0.000 description 1
208000034737 hemoglobinopathy Diseases 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
206010021198 ichthyosis Diseases 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
208000018337 inherited hemoglobinopathy Diseases 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
238000006713 insertion reaction Methods 0.000 description 1
230000002687 intercalation Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
230000000155 isotopic effect Effects 0.000 description 1
208000036546 leukodystrophy Diseases 0.000 description 1
239000002502 liposome Substances 0.000 description 1
230000003137 locomotive effect Effects 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
239000003550 marker Substances 0.000 description 1
238000001819 mass spectrum Methods 0.000 description 1
238000010907 mechanical stirring Methods 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
238000013048 microbiological method Methods 0.000 description 1
239000003094 microcapsule Substances 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
201000002273 mucopolysaccharidosis II Diseases 0.000 description 1
208000022018 mucopolysaccharidosis type 2 Diseases 0.000 description 1
201000000585 muscular atrophy Diseases 0.000 description 1
201000006938 muscular dystrophy Diseases 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
125000006501 nitrophenyl group Chemical group 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
208000002865 osteopetrosis Diseases 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
102000013415 peroxidase activity proteins Human genes 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
150000002988 phenazines Chemical class 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
108060006184 phycobiliprotein Proteins 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920000768 polyamine Polymers 0.000 description 1
229920000570 polyether Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000002243 precursor Substances 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
125000000714 pyrimidinyl group Chemical group 0.000 description 1
229940048084 pyrophosphate Drugs 0.000 description 1
150000003248 quinolines Chemical class 0.000 description 1
239000000376 reactant Substances 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
229920006298 saran Polymers 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
210000000582 semen Anatomy 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000008279 sol Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000011877 solvent mixture Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
229940063673 spermidine Drugs 0.000 description 1
229940063675 spermine Drugs 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
150000005846 sugar alcohols Polymers 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
201000003896 thanatophoric dysplasia Diseases 0.000 description 1
229960000850 trioxysalen Drugs 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1

Landscapes

Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA000553597A 1986-12-29 1987-12-04 Essai pour detecter les sequences d'acides nucleiques dans un echantillon Expired - Fee Related CA1314794C (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US94300686A	1986-12-29	1986-12-29
US943,006		1986-12-29
US2464387A	1987-03-11	1987-03-11
US024,643		1987-03-11

Publications (1)

Publication Number	Publication Date
CA1314794C true CA1314794C (fr)	1993-03-23

Family

ID=26698694

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000553597A Expired - Fee Related CA1314794C (fr)	1986-12-29	1987-12-04	Essai pour detecter les sequences d'acides nucleiques dans un echantillon

Country Status (1)

Country	Link
CA (1)	CA1314794C (fr)

1987
- 1987-12-04 CA CA000553597A patent/CA1314794C/fr not_active Expired - Fee Related

Legal Events

Date	Code	Title	Description
1996-09-24	MKLA	Lapsed

Publication	Publication Date	Title
US5348855A (en)	1994-09-20	Assay for nucleic acid sequences in an unpurified sample
AU601021B2 (en)	1990-08-30	Assay for necleic acid sequences in a sample
CA1295535C (fr)	1992-02-11	Determination rapide des sequences nucleotidiques a l'aide d'un echantillon marque
EP1053352B1 (fr)	2002-09-18	Procedes de detection d'un mauvais appariement
US6238866B1 (en)	2001-05-29	Detector for nucleic acid typing and methods of using the same
US5627030A (en)	1997-05-06	Method of amplification for increasing the sensitivity of detecting nucleic acid-probe target hybrids
EP0777750B1 (fr)	2003-09-24	Procede de depistage a fort rendement en vue de la detection d'alterations de sequences ou genetiques dans des acides nucleiques
US6027877A (en)	2000-02-22	Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, purification of amplified DNA samples and allele identification
US5695926A (en)	1997-12-09	Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support
EP0305145A2 (fr)	1989-03-01	Méthodes et sondes pour détecter des acides nucléiques
EP0530998B1 (fr)	1996-11-13	Détection de sequences nucléotidiques complémentaires
JPH08501689A (ja)	1996-02-27	改良型の鎖置換アッセイおよびそれに有用な複合体
AU706205B2 (en)	1999-06-10	Homogeneous DNA probe titration assay
US5538872A (en)	1996-07-23	Method of preparing nucleotide probes using a bridging complement
JPH06209797A (ja)	1994-08-02	カンジダ・アルビカンス（Ｃａｎｄｉｄａａｌｂｉｃａｎｓ）の診断的研究のための特異的遺伝子のプローブ
EP0235727A2 (fr)	1987-09-09	DNA-diagnostique rapide pour les microbes
JPS62265999A (ja)	1987-11-18	核酸含有試料中の微生物の検出
EP0622464A2 (fr)	1994-11-02	Procédé de dosage d'acide nucléique
CA1314794C (fr)	1993-03-23	Essai pour detecter les sequences d'acides nucleiques dans un echantillon
US6306657B1 (en)	2001-10-23	Polynucleotide probe and kit for amplifying signal detection in hybridization assays
EP0311388B1 (fr)	1995-02-22	Procédé rapide pour identifier une séquence spécifique d'acide nucléique
JPH0646899A (ja)	1994-02-22	核酸結合因子の検出のための迅速な検定